Kainos Medicine, Inc. announced a private placement of 4,681,638 shares for gross proceeds of KRW 2,670 per share for gross proceeds of KRW 12,499,973,460 on October 14, 2021. The transaction is expected to close on November 12, 2021. The transaction has been approved by the board of directors of the company. The shares to be issued are restricted in nature.